Skip to main content
Home
Home

Meta navigation

  • Contact
  • Donate
  • Jobs

Main navigation

  • For patients
  • For researchers
  • About us
  • Network

Leukemia

2 currently open clinical trials
Treatment with ivosidenib or enasidenib for patients with mutations in enzymes (IDH1 or IDH2 mutation)
HOVON 150
Chemotherapy augmented by gilteritinib or midostaurin in patients with acute myeloid leukemia
HOVON 156
All cancer types

Footer

Footer main navigation

  • For patients
  • For researchers
  • About us
  • Network

Footer Quicklinks

  • Trials
  • Events
  • News
  • Portal

Footer meta navigation

  • Contact
  • Donate
  • Jobs
Newsletter subscription

Follow us on

  • EN
  • DE
  • FR

© 2018 SAKK - Swiss Group for Clinical Cancer Research, Effingerstrasse 33, 3008 Bern - Switzerland

Footer navigation

  • Imprint

Mobile main navigation

  • For patients
    • For patients
    • Participate in a trial
    • Genetic Counseling
    • FAQ
    • Glossary
    • Downloads
  • For researchers
    • For researchers
    • Research groups
    • Young Oncology Academy
    • Grants and fellowships
    • Electronic Data Capture (EDC)
  • About us
    • About us
    • Mission statement
    • Organization
    • Board and Executive Board
    • Patient Advisory Board
    • Support and collaborations
    • Media and publications
  • Network

Mobile meta navigation

  • Contact
  • Donate
  • Jobs
    • Vacancies
    • Work for us
    • Our values
    • Work–life balance
    • Wages and benefits
    • Staff development

Mobile footer navigation

  • Imprint
  • EN
  • DE
  • FR

Mobile quicklinks

  • Trials
  • Events
  • News
  • Portal

Quicklinks

  • Trials
  • Events
  • News
  • Portal